PHOX2B and neuroblastoma: However, very recent data suggest that PHOX2B overexpression is likely pathogenic in the earliest steps of neuroblastoma growth, associated with poor neuroblast differentiation and expansion, while in the final metastatic phase it seems to protect against aggressive migration capability [13].